Ibrutinib treatment inhibits breast cancer progression and metastasis by inducing conversion of myeloid-derived suppressor cells to dendritic cells.
Varikuti S, Singh B, Volpedo G, Ahirwar DK, Jha BK, Saljoughian N, Viana AG, Verma C, Hamza O, Halsey G, Holcomb EA, Maryala RJ, Oghumu S, Ganju RK, Satoskar AR.
Varikuti S, et al. Among authors: halsey g.
Br J Cancer. 2020 Mar;122(7):1005-1013. doi: 10.1038/s41416-020-0743-8. Epub 2020 Feb 6.
Br J Cancer. 2020.
PMID: 32025027
Free PMC article.